- Southwest Roundup: Jennifer D. Duell
Like many cities across the nation, Phoenix has dreams of becoming a biotechnology Mecca. But unlike other cities, Phoenix is actually doing something to make that dream a reality.
- Random Samples.
Companies: Varian deployed field specialists to help US customers develop application-specific GC solutions...Sartotius AG, which owned 76% of Vivascience, acquired the remaining 24% on September 1st, 2000...Waters expanded its online marketplace into the UK, Netherlands, Belgium, Canada, Puerto Rico and Mexico, and plans to extend it into more European countries ......
- Cell Therapeutics announces agreement to acquire
Systems Medicine and Gains Global Rights to Brostallicin, a new cancer
killing agent.
Cell Therapeutics, Inc. (Seattle, WA) entered into an agreement to acquire Systems Medicine, Inc. (Tucson, AZ), a privately held oncology company, in a stock for stock merger valued at $20 million. SMi stockholders could also receive a maximum of $15 million in additional consideration, payable in either cash or ......
- TGen and Affymetrix partner to use GeneChip DNA
analysis.
Affymetrix, Inc. (Santa Clara, CA), and the Translational Genomics Research Institute (Phoenix, AZ) have entered into a non-exclusive agreement under which TGen will offer genotyping services to their collaborators and NIH funded core facility programs using Affymetrix GeneChip brand DNA analysis technology. TGen currently runs gene expression core facility programs ......
- Renowned Physician Embarks on Scripps' Huge Genomics Project
Dr. Eric Topol's reaction upon arriving in La Jolla three months ago with his family was typical of most first-time visitors'. "I wish we got here years ago, in every respect," said Topol, the newly appointed chief academic officer for La Jolla-based Scripps Health. 4 But unlike most, his affinity ......
- Asian Life Science Investments Roar
Ahead.
As the world enters the "post genomic era," one region that has been conspicuously absent from the technology spotlight prepares to take a role in the next stage of life science research and commerce. As Asia returns from its crippling financial crisis, parts of the region appear to be wasting ......
- Mexico.
Mexico: The first facilities of Mexico's 11th national health institute, Mexico City's National Institute of Genomic Medicine (INMEGEN), are scheduled to open this year. Focused on diseases affecting the country's population, INMEGEN will conduct research on cancer, pharmacogenomics, population genomics as well as infectious, cardiovascular and metabolic diseases. The first ......